Poliscio Analytics LLC
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • FOIA Services
  • About
    • About PoliScio
    • Leadership
    • Newsroom
  • Contact
Select Page
Perp Walk: “Wild West” Gold Rush in a $90 Trillion Market

Perp Walk: “Wild West” Gold Rush in a $90 Trillion Market

by John A. Jenkins | Jun 4, 2026 | CFTC, Cryptocurrency, FOIA, News Media, Politics

FOIAengine: Requests Pile Up, As State and Federal Lawmakers Square Off Months before the regulatory chaos around prediction markets exploded into courtrooms, state houses, and the White House, sophisticated observers were already paying attention. More than 170...
Hard Questions for NASA Amid Warning of Russian Cyberattacks

Hard Questions for NASA Amid Warning of Russian Cyberattacks

by John A. Jenkins | May 20, 2026 | FOIA, NASA

FOIA Requests From Former CIA, FBI agents  Across the United States, cybersecurity teams at federal agencies, defense contractors, telecom firms, and critical infrastructure operators are being warned to prepare for the next Russian cyberattack. In March, the Federal...
A Litigation Wave for Biotech’s Medpace

A Litigation Wave for Biotech’s Medpace

by John A. Jenkins | May 14, 2026 | FOIA, Litigation, Pharmaceuticals, SEC

FOIAengine: Requests to SEC Preceded Stock Troubles and a Surprise Resignation For a company that most Americans have never heard of, Medpace Holdings, Inc. (NASD:MEDP) sits remarkably close to the center of the modern drug-development economy. The Cincinnati-based...
Beta Bionics: The Rise and Decline of a High-Flying IPO

Beta Bionics: The Rise and Decline of a High-Flying IPO

by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market

How FOIA Requests Signaled Problems With a “Bionic Pancreas”  At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
Beta Bionics: The Rise and Decline of a High-Flying IPO

FOIA Requests Point to New Pressure Over Abortion Drugs

by John A. Jenkins | Apr 1, 2026 | FDA, FOIA

FOIAengine: Advocates on Both Sides Push FDA for Data as a Senate Investigation Begins  Even before Sen. Josh Hawley (R-Mo.) walked into a March 11 news conference to kick off an effort to ban the abortion drug mifepristone as unsafe – and days before he opened an...
« Older Entries
  • Terms of Service
  • Privacy Policy
  • Text-to-Speech
Copyright 2026 PoliScio Analytics LLC